Position in VKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,141,939
+$189,396 QoQ
Shares Held
29,273
0.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#154
of 432 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kintayl Capital LP holds $2,744,916 across 4 Biotechnology names. VKTX ranks #2 (41.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
22,689 | $1,602,977 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
This page
|
29,273 | $1,141,939 | |
| 3 | 114,111 | $0 | |||
| 4 | 8,476 | $0 |
All Filings in VKTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,141,939 | 29,273 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $952,543 | 29,273 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,062,524 | 87,053 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,633,019 | 100,191 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,434,585 | 129,607 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,414,347 | 99,973 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,051,998 | 50,994 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||